Hopantenic acid (Calcium hopantenate)

Calcium hopantenate, marketed under trade names such as Pantogram and Calcium panthotenate (among others) mainly in Russia and Japan, is a nootropic drug primarily utilized for its cognitive-enhancing properties.  Currently, its indications cover a wide array of conditions, including neurodevelopmental disorders like ADHD and developmental delays in children, as well as cognitive problems in adults of various etiologies, subsuming reduced blood flow to the brain due to hardening of the arteries and neurodegenerative diseases like Alzheimer’s.  It is also used to treat epilepsy with intellectual disabilities along with anticonvulsants, schizophrenia with brain-related issues together with neuroleptics, and to help control tardive dyskinesia caused by neuroleptics.

First synthesized in the mid-20th century, it has since gained substantial interest in the pharmaceutical and medical research communities, becoming the subject of multiple studies aimed at understanding its precise mechanisms of action and exploring its therapeutic potential, possibly further expanding its clinical applications. While structurally similar to pantothenic acid (vitamin B5), it is uniquely tailored to readily cross the blood-brain barrier and impact the central nervous system.

The effectiveness of calcium hopantenate is attributed to its diverse method of action. This molecule influences the gamma-aminobutyric acid (GABA) pathway, which is essential for modulating neuronal excitability across the nervous system. Calcium hopantenate functions as a GABAB receptor sensitizer; hence, it augments inhibitory neurotransmission. This may result in elevated dopamine levels in the brain, correlated with enhanced mood, attention, and executive function. Calcium hopantenate also affects the metabolism of glutamate, a crucial neurotransmitter implicated in synaptic plasticity, learning, and memory. The medicine helps balance the signals that excite and calm the brain, which can prevent seizures and create a more stable brain environment, especially helpful for people with cognitive and emotional challenges.  Given that GABA-glutamate imbalance has been implicated in Autism Spectrum Disorder, calcium hopantenate could potentially offer some benefit in this neurodivergent condition.

Furthermore, research indicates that calcium hopantenate may have neuroprotective characteristics. It has been demonstrated to improve the resistance of neural cells against oxidative stress and neurotoxins, prevalent in neurodegenerative illnesses. This protective effect is thought to be facilitated by its capacity to enhance the synthesis of neurotrophic factors and other essential proteins implicated in brain growth and repair.

Moreover, some studies suggest that calcium hopantenate may contribute to the augmentation of neuronal energy metabolism. It is believed to enhance the absorption and utilization of glucose by neuronal cells, thus ensuring a consistent energy supply essential for proper cerebral function. This energy enhancement can lead to enhanced cognitive performance and reduced mental fatigue.

Calcium ions are essential for various cellular functions, such as neurotransmitter release, signal transmission, and enzymatic activity. Calcium hopantenate could assist in modulating intracellular calcium concentrations, facilitating efficient and uninterrupted neural functions.

Evidence indicates that calcium hopantenate may affect the cholinergic system, augmenting the function of cholinergic neurons. Additionally, it may increase the synthesis and release of acetylcholine, potentially playing a crucial role in preserving cognitive processes and averting cognitive decline linked to aging and neurodegenerative disorders.

It has also been found to promote normalization of GABA in chronic alcohol intoxication and the subsequent discontinuation of ethanol, as well as exhibit analgesic effects.

Calcium hopantenate was able to significantly improve attention, decrease hyperactivity, and enhance overall function in children with ADHD over the course of four months (vs. placebo).

Benefits of taking calcium hopantenate

• enhanced focus and attention;
• lessened anxiety;
• stable, positive mood;
• mild stimulation;
• decreased impulsivity and emotional hyperreactivity;
• enhanced memory and learning;
• improved executive function;
• reduced mental fatigue;
• prevents mental overload;
• might alleviate the symptoms of autism;
• neuroprotective properties;
• possible aid in alcohol use cessation.

Side effects

• nausea;
• vomiting;
• abdominal pain;
• allergic reactions (skin rash, conjunctivitis, rhinitis).

Interactions

• CNS stimulants (synergy or overstimulation);
• CNS depressants (excessive sedation, motor impairment);
• SSRIs (potential interaction);
• TCAs (potential interaction);
• antacids (reduced absorption).

Contraindications

• severe renal impairment.

Dosage

The usual recommended adult dose of calcium hopantenate ranges from 250 mg to 1000 mg per day, divided into two or three doses.

In some cases, improvements in cognitive function and mood may be observed within a few days; it could, however, take several weeks of consistent use for its beneficial effects to become manifest.

Taking calcium hopantenate with meals enhances its absorption and reduces the risk of gastrointestinal discomfort. It is also generally advised to take the last dose of the day early in the afternoon to avoid potential interference with sleep, considering its stimulating properties.